MP Materials Reports First Quarter 2026 Results
Record NdPr production of 917 metric tons, a 63% increase year over year
Record NdPr sales of 1,006 metric tons1, a 117% increase year over year
Record Q1 REO production of 12,983 metric tons, a 6% increase year over year
Generated
Generated
Generated
Broke ground on 10X magnetics facility
“MP Materials delivered record NdPr production and sales with solid Adjusted EBITDA generation in the first quarter,” said
First Quarter 2026 Consolidated Financial Highlights
|
|
For the three months ended
|
|
2026 vs. 2025 |
||||||||||
|
(in thousands, except per share data, unaudited) |
|
2026 |
|
|
|
2025 |
|
|
Amount
|
|
% Change |
||
|
Financial Measures: |
|
|
|
|
|
|
|
||||||
|
Revenue |
$ |
90,649 |
|
|
$ |
60,810 |
|
|
$ |
29,839 |
|
49 |
% |
|
Price protection agreement income |
$ |
42,273 |
|
|
$ |
— |
|
|
$ |
42,273 |
|
N/M |
|
|
Net loss |
$ |
(7,968 |
) |
|
$ |
(22,648 |
) |
|
$ |
14,680 |
|
65 |
% |
|
Adjusted EBITDA2 |
$ |
36,610 |
|
|
$ |
(2,696 |
) |
|
$ |
39,306 |
|
N/M |
|
|
Adjusted Net Income (Loss)2 |
$ |
6,652 |
|
|
$ |
(19,898 |
) |
|
$ |
26,550 |
|
N/M |
|
|
Diluted loss per common share |
$ |
(0.04 |
) |
|
$ |
(0.14 |
) |
|
$ |
0.10 |
|
71 |
% |
|
Adjusted Diluted EPS2 |
$ |
0.03 |
|
|
$ |
(0.12 |
) |
|
$ |
0.15 |
|
N/M |
|
|
N/M = Not meaningful. |
|||||||||||||
|
1 Includes sales volumes, revenue, and profits recognized in the Materials Segment on intercompany transactions with the Magnetics Segment. |
|||||||||||||
|
2 See “Use of Non-GAAP Financial Measures” below for the definitions. See tables below for reconciliations of non-GAAP financial measures to their most directly comparable GAAP financial measures. |
|||||||||||||
First Quarter 2026 Consolidated Review
Total revenue increased 49% year over year to
Adjusted EBITDA increased by
Adjusted Net Income improved by
Net loss improved by
Diluted loss per common share and Adjusted Diluted EPS improved by
First Quarter 2026 Segment Financial Highlights
|
|
For the three months ended
|
|
2026 vs. 2025 |
|||||||||||
|
(in thousands, unaudited) |
|
2026 |
|
|
|
2025 |
|
|
$ Change |
|
% Change |
|||
|
Segment Financials: |
|
|
|
|
|
|
|
|||||||
|
Revenue |
|
|
|
|
|
|
|
|||||||
|
Materials Segment |
$ |
72,177 |
|
|
$ |
55,619 |
|
|
$ |
16,558 |
|
|
30 |
% |
|
Magnetics Segment |
|
21,078 |
|
|
|
5,191 |
|
|
|
15,887 |
|
|
306 |
% |
|
Intercompany eliminations(1) |
|
(2,606 |
) |
|
|
— |
|
|
|
(2,606 |
) |
|
N/M |
|
|
Total revenue |
$ |
90,649 |
|
|
$ |
60,810 |
|
|
$ |
29,839 |
|
|
49 |
% |
|
|
|
|
|
|
|
|
|
|||||||
|
Segment Adjusted EBITDA(2) |
|
|
|
|
|
|
|
|||||||
|
Materials Segment |
$ |
36,732 |
|
|
$ |
3,758 |
|
|
$ |
32,974 |
|
|
877 |
% |
|
Magnetics Segment |
|
9,592 |
|
|
|
493 |
|
|
|
9,099 |
|
|
N/M |
|
|
Total Segment Adjusted EBITDA |
$ |
46,324 |
|
|
$ |
4,251 |
|
|
$ |
42,073 |
|
|
990 |
% |
|
Corporate and other(3) |
|
(9,587 |
) |
|
|
(6,947 |
) |
|
|
(2,640 |
) |
|
(38 |
)% |
|
Intercompany eliminations(1) |
|
(127 |
) |
|
|
— |
|
|
|
(127 |
) |
|
N/M |
|
|
Adjusted EBITDA(4) |
$ |
36,610 |
|
|
$ |
(2,696 |
) |
|
$ |
39,306 |
|
|
N/M |
|
|
N/M = Not meaningful. |
||||||||||||||
|
(1) |
Represents the elimination of intercompany revenues and Segment Adjusted EBITDA associated with NdPr oxide sales made by the Materials Segment to the Magnetics Segment. |
|
(2) |
Segment Adjusted EBITDA is management’s measure of profit or loss required by GAAP in assessing segment performance and deciding how to allocate the Company’s resources. See “Segment Information” below for further information. |
|
(3) |
Corporate and other is not considered a reportable segment, and is presented solely to reconcile the total of Segment Adjusted EBITDA to Adjusted EBITDA on a consolidated basis. Corporate and other represents costs incurred at the corporate level that are not allocated to the operating segments, specifically relating to executive compensation, investor relations, other corporate costs, and the remaining unallocated costs for shared service functions such as legal, information technology, human resources, finance and accounting and supply chain. |
|
(4) |
See “Use of Non-GAAP Financial Measures” below for definition. See table below for a reconciliation of Adjusted EBITDA to its most directly comparable GAAP financial measure, net income or loss. |
First Quarter 2026 Materials Segment Financial and Operational Results
|
|
For the three months ended
|
|
2026 vs. 2025 |
|||||||||
|
(unaudited) |
|
2026 |
|
|
2025 |
|
Amount
|
|
% Change |
|||
|
Revenue: |
(in thousands) |
|
|
|||||||||
|
NdPr oxide and metal |
$ |
71,136 |
|
$ |
24,321 |
|
$ |
46,815 |
|
|
192 |
% |
|
Rare earth concentrate |
|
— |
|
|
30,115 |
|
|
(30,115 |
) |
|
N/M |
|
|
Other revenue |
|
1,041 |
|
|
1,183 |
|
|
(142 |
) |
|
(12 |
)% |
|
Total Materials Segment revenue |
$ |
72,177 |
|
$ |
55,619 |
|
$ |
16,558 |
|
|
30 |
% |
|
|
|
|
|
|
|
|
|
|||||
|
Price protection agreement income |
$ |
42,273 |
|
$ |
— |
|
$ |
42,273 |
|
|
N/M |
|
|
|
|
|
|
|
|
|
|
|||||
|
Segment Adjusted EBITDA(1) |
$ |
36,732 |
|
$ |
3,758 |
|
$ |
32,974 |
|
|
877 |
% |
|
|
|
|
|
|
|
|
|
|||||
|
Key Performance Indicators(2): |
(in whole units) |
|
|
|||||||||
|
Separated NdPr products |
|
|
|
|
|
|
|
|||||
|
NdPr Production Volume (MTs) |
|
917 |
|
|
563 |
|
|
354 |
|
|
63 |
% |
|
NdPr Sales Volume (MTs) |
|
1,006 |
|
|
464 |
|
|
542 |
|
|
117 |
% |
|
Rare earth concentrate |
|
|
|
|
|
|
|
|||||
|
REO Production Volume (MTs) |
|
12,983 |
|
|
12,213 |
|
|
770 |
|
|
6 |
% |
|
N/M = Not meaningful. |
||||||||||||
| (1) |
See “Segment Information” below for further information. |
| (2) |
See “Key Performance Indicators” below for definitions and further information. |
First Quarter 2026 Materials Segment Review
Materials Segment revenue increased by 30% to
Materials Segment Adjusted EBITDA increased by
First Quarter 2026 Magnetics Segment Financial Results
|
|
For the three months ended
|
|
2026 vs. 2025 |
||||||||
|
(in thousands, unaudited) |
|
2026 |
|
|
2025 |
|
$ Change |
|
% Change |
||
|
Magnetic precursor products revenue |
$ |
21,078 |
|
$ |
5,191 |
|
$ |
15,887 |
|
306 |
% |
|
|
|
|
|
|
|
|
|
||||
|
Segment Adjusted EBITDA(1) |
$ |
9,592 |
|
$ |
493 |
|
$ |
9,099 |
|
N/M |
|
|
N/M = Not meaningful. |
|||||||||||
| (1 | ) |
See “Segment Information” below for further information. |
First Quarter 2026 Magnetics Segment Review
Magnetics Segment revenue increased by
|
|
|||||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||
|
|
|
|
|
||||
|
( |
|
||||||
|
Assets |
|
|
|
||||
|
Current assets |
|
|
|
||||
|
Cash and cash equivalents |
$ |
886,277 |
|
|
$ |
1,166,011 |
|
|
Short-term investments |
|
852,058 |
|
|
|
664,275 |
|
|
Total cash, cash equivalents and short-term investments |
|
1,738,335 |
|
|
|
1,830,286 |
|
|
Trade accounts receivable |
|
47,291 |
|
|
|
14,642 |
|
|
Other receivables |
|
71,981 |
|
|
|
132,042 |
|
|
Inventories |
|
169,192 |
|
|
|
171,560 |
|
|
Prepaid expenses and other current assets |
|
20,104 |
|
|
|
17,271 |
|
|
Total current assets |
|
2,046,903 |
|
|
|
2,165,801 |
|
|
Non-current assets |
|
|
|
||||
|
Property, plant and equipment, net |
|
1,434,231 |
|
|
|
1,369,817 |
|
|
Inventories |
|
96,454 |
|
|
|
80,539 |
|
|
Price protection agreement upfront asset, net |
|
198,503 |
|
|
|
209,668 |
|
|
Other non-current assets |
|
64,112 |
|
|
|
38,335 |
|
|
Total non-current assets |
|
1,793,300 |
|
|
|
1,698,359 |
|
|
Total assets |
$ |
3,840,203 |
|
|
$ |
3,864,160 |
|
|
Liabilities, redeemable preferred stock and stockholders’ equity |
|
|
|
||||
|
Current liabilities |
|
|
|
||||
|
Accounts and construction payable |
$ |
32,988 |
|
|
$ |
36,655 |
|
|
Accrued liabilities |
|
99,412 |
|
|
|
95,086 |
|
|
Current portion of long-term debt |
|
67,499 |
|
|
|
67,411 |
|
|
Deferred revenue |
|
62,062 |
|
|
|
74,301 |
|
|
Other current liabilities |
|
23,291 |
|
|
|
25,596 |
|
|
Total current liabilities |
|
285,252 |
|
|
|
299,049 |
|
|
Non-current liabilities |
|
|
|
||||
|
Long-term debt, net of current portion |
|
932,942 |
|
|
|
931,330 |
|
|
Deferred revenue |
|
77,849 |
|
|
|
83,889 |
|
|
Deferred government grant |
|
24,523 |
|
|
|
22,101 |
|
|
Deferred investment tax credit |
|
36,262 |
|
|
|
26,860 |
|
|
Deferred income taxes |
|
35,231 |
|
|
|
51,558 |
|
|
Other non-current liabilities |
|
67,386 |
|
|
|
57,005 |
|
|
Total non-current liabilities |
|
1,174,193 |
|
|
|
1,172,743 |
|
|
Total liabilities |
|
1,459,445 |
|
|
|
1,471,792 |
|
|
Commitments and contingencies |
|
|
|
||||
|
Redeemable preferred stock: |
|
|
|
||||
|
Series A cumulative perpetual convertible preferred stock ( |
|
413,611 |
|
|
|
413,611 |
|
|
Stockholders’ equity: |
|
|
|
||||
|
Preferred stock, undesignated ( |
|
— |
|
|
|
— |
|
|
Common stock ( |
|
19 |
|
|
|
19 |
|
|
Additional paid-in capital |
|
1,967,757 |
|
|
|
1,970,970 |
|
|
Retained earnings |
|
226,460 |
|
|
|
234,428 |
|
|
Accumulated other comprehensive income (loss) |
|
(42 |
) |
|
|
387 |
|
|
|
|
(227,047 |
) |
|
|
(227,047 |
) |
|
Total stockholders’ equity |
|
1,967,147 |
|
|
|
1,978,757 |
|
|
Total liabilities, redeemable preferred stock and stockholders’ equity |
$ |
3,840,203 |
|
|
$ |
3,864,160 |
|
|
|
|||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||
|
|
|
|
|
||||
|
( |
For the three months ended |
||||||
|
|
2026 |
|
|
|
2025 |
|
|
|
Revenue |
$ |
90,649 |
|
|
$ |
60,810 |
|
|
Price protection agreement income |
|
42,273 |
|
|
|
— |
|
|
Operating costs and expenses: |
|
|
|
||||
|
Cost of sales (excluding depreciation, depletion and amortization) |
|
74,245 |
|
|
|
48,831 |
|
|
Selling, general and administrative |
|
33,640 |
|
|
|
24,166 |
|
|
Depreciation, depletion and amortization |
|
32,137 |
|
|
|
21,384 |
|
|
Start-up costs |
|
5,889 |
|
|
|
976 |
|
|
Advanced projects and development |
|
1,905 |
|
|
|
474 |
|
|
Other operating costs and expenses (income), net |
|
9,228 |
|
|
|
(243 |
) |
|
Total operating costs and expenses, net |
|
157,044 |
|
|
|
95,588 |
|
|
Operating loss |
|
(24,122 |
) |
|
|
(34,778 |
) |
|
Interest expense, net |
|
(9,846 |
) |
|
|
(7,615 |
) |
|
Other income, net |
|
20,326 |
|
|
|
15,218 |
|
|
Loss before income taxes |
|
(13,642 |
) |
|
|
(27,175 |
) |
|
Income tax benefit |
|
5,674 |
|
|
|
4,527 |
|
|
Net loss |
$ |
(7,968 |
) |
|
$ |
(22,648 |
) |
|
|
|
|
|
||||
|
Loss per common share: |
|
|
|
||||
|
Basic |
$ |
(0.04 |
) |
|
$ |
(0.14 |
) |
|
Diluted |
$ |
(0.04 |
) |
|
$ |
(0.14 |
) |
|
|
|
|
|
||||
|
Weighted-average shares outstanding: |
|
|
|
||||
|
Basic |
|
178,019,549 |
|
|
|
163,764,345 |
|
|
Diluted |
|
178,019,549 |
|
|
|
163,764,345 |
|
|
|
|||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
|
|
|
|
|
||||
|
|
For the three months ended |
||||||
|
( |
|
2026 |
|
|
|
2025 |
|
|
Operating activities: |
|
|
|||||
|
Net loss |
$ |
(7,968 |
) |
|
$ |
(22,648 |
) |
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
||||
|
Depreciation, depletion and amortization |
|
32,137 |
|
|
|
21,384 |
|
|
Accretion of discount on short-term investments |
|
(5,773 |
) |
|
|
(5,691 |
) |
|
Stock-based compensation expense |
|
12,930 |
|
|
|
7,353 |
|
|
Amortization of debt discount and debt issuance costs |
|
1,840 |
|
|
|
1,033 |
|
|
Lower of cost or net realizable value reserve |
|
— |
|
|
|
3,164 |
|
|
Deferred income taxes |
|
(5,178 |
) |
|
|
(4,558 |
) |
|
Other |
|
(2,796 |
) |
|
|
(6,932 |
) |
|
Decrease (increase) in operating assets: |
|
|
|
||||
|
Trade accounts receivable |
|
(32,649 |
) |
|
|
(318 |
) |
|
Other receivables |
|
48,018 |
|
|
|
(57,000 |
) |
|
Inventories |
|
(8,853 |
) |
|
|
(31,103 |
) |
|
Prepaid expenses, other current and non-current assets |
|
(7,365 |
) |
|
|
(6,991 |
) |
|
Increase (decrease) in operating liabilities: |
|
|
|
||||
|
Accounts payable and accrued liabilities |
|
(2,831 |
) |
|
|
(1,786 |
) |
|
Deferred revenue |
|
(19,196 |
) |
|
|
44,809 |
|
|
Deferred government grant |
|
3,380 |
|
|
|
2,723 |
|
|
Other current and non-current liabilities |
|
(7,605 |
) |
|
|
(6,637 |
) |
|
Net cash used in operating activities |
|
(1,909 |
) |
|
|
(63,198 |
) |
|
Investing activities: |
|
|
|
||||
|
Additions to property, plant and equipment |
|
(77,376 |
) |
|
|
(30,467 |
) |
|
Purchases of short-term investments |
|
(576,555 |
) |
|
|
(364,680 |
) |
|
Proceeds from sales of short-term investments |
|
15,840 |
|
|
|
23,164 |
|
|
Proceeds from maturities of short-term investments |
|
378,279 |
|
|
|
354,613 |
|
|
Proceeds from sale of property, plant and equipment |
|
— |
|
|
|
1,666 |
|
|
Net cash used in investing activities |
|
(259,812 |
) |
|
|
(15,704 |
) |
|
Financing activities: |
|
|
|
||||
|
Principal payments on debt obligations |
|
(912 |
) |
|
|
(1,361 |
) |
|
Tax withholding on stock-based awards |
|
(17,634 |
) |
|
|
(3,642 |
) |
|
Net cash used in financing activities |
|
(18,546 |
) |
|
|
(5,003 |
) |
|
Net change in cash, cash equivalents and restricted cash |
|
(280,267 |
) |
|
|
(83,905 |
) |
|
Cash, cash equivalents and restricted cash beginning balance |
|
1,167,359 |
|
|
|
283,603 |
|
|
Cash, cash equivalents and restricted cash ending balance |
$ |
887,092 |
|
|
$ |
199,698 |
|
|
|
|
|
|
||||
|
Reconciliation of cash, cash equivalents and restricted cash: |
|
|
|
||||
|
Cash and cash equivalents |
$ |
886,277 |
|
|
$ |
198,343 |
|
|
Restricted cash, current |
|
815 |
|
|
|
815 |
|
|
Restricted cash, non-current |
|
— |
|
|
|
540 |
|
|
Total cash, cash equivalents and restricted cash |
$ |
887,092 |
|
|
$ |
199,698 |
|
|
Reconciliation of GAAP Net Loss to Non-GAAP Adjusted EBITDA |
|||||||
|
|
|
|
|
||||
|
|
For the three months ended |
||||||
|
(in thousands, unaudited) |
|
2026 |
|
|
|
2025 |
|
|
Net loss |
$ |
(7,968 |
) |
|
$ |
(22,648 |
) |
|
Adjusted for: |
|
|
|
||||
|
Depreciation, depletion and amortization |
|
32,137 |
|
|
|
21,384 |
|
|
Interest expense, net |
|
9,846 |
|
|
|
7,615 |
|
|
Income tax benefit |
|
(5,674 |
) |
|
|
(4,527 |
) |
|
Stock-based compensation expense(1) |
|
12,867 |
|
|
|
7,353 |
|
|
Initial start-up costs(2) |
|
4,853 |
|
|
|
772 |
|
|
Transaction-related and other costs(3) |
|
10,489 |
|
|
|
2,816 |
|
|
Accretion of asset retirement and environmental obligations(4) |
|
386 |
|
|
|
373 |
|
|
Loss on disposals of long-lived assets, net(4) |
|
— |
|
|
|
(616 |
) |
|
Other income, net(5) |
|
(20,326 |
) |
|
|
(15,218 |
) |
|
Adjusted EBITDA |
$ |
36,610 |
|
|
$ |
(2,696 |
) |
|
(1) |
Principally included in “Selling, general and administrative” within our unaudited Condensed Consolidated Statements of Operations. |
|
(2) |
Included in “Start-up costs” within our unaudited Condensed Consolidated Statements of Operations and excludes any applicable stock-based compensation, which is included in the “Stock-based compensation expense” line above. Primarily relates to certain costs incurred in connection with the commissioning and starting up of our initial magnet-making capabilities at the Independence Facility prior to the achievement of commercial production. |
|
(3) |
Pertains to legal, consulting, and advisory services, and other costs associated with specific matters or transactions, including litigation matters, potential acquisitions, mergers, or other investments. For the three months ended |
|
(4) |
Included in “Other operating costs and expenses (income), net” within our unaudited Condensed Consolidated Statements of Operations. |
|
(5) |
Principally comprised of interest and investment income. |
|
Reconciliation of GAAP Net Loss to Non-GAAP Adjusted Net Income (Loss) |
|||||||
|
|
|
|
|
||||
|
|
For the three months ended |
||||||
|
(in thousands, unaudited) |
|
2026 |
|
|
|
2025 |
|
|
Net loss |
$ |
(7,968 |
) |
|
$ |
(22,648 |
) |
|
Adjusted for: |
|
|
|
||||
|
Stock-based compensation expense(1) |
|
12,867 |
|
|
|
7,353 |
|
|
Initial start-up costs(2) |
|
4,853 |
|
|
|
772 |
|
|
Transaction-related and other costs(3) |
|
10,489 |
|
|
|
2,816 |
|
|
Loss on disposals of long-lived assets, net(4) |
|
— |
|
|
|
(616 |
) |
|
Change in fair value of derivative instrument(5) |
|
(4,098 |
) |
|
|
(6,997 |
) |
|
Tax impact of adjustments above(6) |
|
(9,491 |
) |
|
|
(578 |
) |
|
Adjusted Net Income (Loss) |
$ |
6,652 |
|
|
$ |
(19,898 |
) |
|
(1) |
Principally included in “Selling, general and administrative” within our unaudited Condensed Consolidated Statements of Operations. |
|
(2) |
Included in “Start-up costs” within our unaudited Condensed Consolidated Statements of Operations and excludes any applicable stock-based compensation, which is included in the “Stock-based compensation expense” line above. Primarily relates to certain costs incurred in connection with the commissioning and starting up of our initial magnet-making capabilities at the Independence Facility prior to the achievement of commercial production. |
|
(3) |
Pertains to legal, consulting, and advisory services, and other costs associated with specific matters or transactions, including litigation matters, potential acquisitions, mergers, or other investments. For the three months ended |
|
(4) |
Included in “Other operating costs and expenses (income), net” within our unaudited Condensed Consolidated Statements of Operations. |
|
(5) |
Included in “Other income, net” within our unaudited Condensed Consolidated Statements of Operations. |
|
(6) |
Tax impact of adjustments is calculated using an adjusted effective tax rate, which excludes the impact of discrete tax costs and benefits, to each adjustment. The adjusted effective tax rates were 39.4% and 17.4% for the three months ended |
|
Reconciliation of GAAP Diluted Loss per Common Share to Non-GAAP Adjusted Diluted EPS |
|||||||
|
|
|
|
|
||||
|
|
For the three months ended |
||||||
|
(unaudited) |
|
2026 |
|
|
|
2025 |
|
|
Diluted loss per common share |
$ |
(0.04 |
) |
|
$ |
(0.14 |
) |
|
Adjusted for: |
|
|
|
||||
|
Stock-based compensation expense |
|
0.07 |
|
|
|
0.04 |
|
|
Initial start-up costs |
|
0.02 |
|
|
|
— |
|
|
Transaction-related and other costs |
|
0.05 |
|
|
|
0.02 |
|
|
Change in fair value of derivative instrument |
|
(0.02 |
) |
|
|
(0.04 |
) |
|
Tax impact of adjustments above(1) |
|
(0.05 |
) |
|
|
— |
|
|
Adjusted Diluted EPS |
$ |
0.03 |
|
|
$ |
(0.12 |
) |
|
|
|
|
|
||||
|
Diluted weighted-average shares outstanding |
|
178,019,549 |
|
|
|
163,764,345 |
|
|
Assumed conversion of Series A Preferred Stock(2) |
|
13,320,013 |
|
|
|
— |
|
|
Assumed conversion of Warrant(2) |
|
5,577,049 |
|
|
|
— |
|
|
Assumed conversion of 2026 Notes(2) |
|
395,908 |
|
|
|
— |
|
|
Assumed conversion of restricted stock units(2) |
|
1,017,347 |
|
|
|
— |
|
|
Assumed conversion of performance stock units(2) |
|
524,451 |
|
|
|
— |
|
|
Adjusted diluted weighted-average shares outstanding |
|
198,854,317 |
|
|
|
163,764,345 |
|
|
(1) |
Tax impact of adjustments is calculated using an adjusted effective tax rate, which excludes the impact of discrete tax costs and benefits, to each adjustment. The adjusted effective tax rates were 39.4% and 17.4% for the three months ended |
|
(2) |
For the three months ended |
Conference Call Details
About
Join the
We routinely post important information on our website, including corporate and investor presentations and financial information. We intend to use our website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Such disclosures will be included in the Investors section of our website. Accordingly, investors should monitor such portion of our website, in addition to following our press releases,
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Accordingly, the Company cautions that the forward-looking statements contained herein are qualified by important factors that could cause actual results to differ materially from those reflected by such statements. These forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, the heightened significance of the development of the Company’s midstream and downstream operations, including ramping its separation capabilities, and its ability to vertically integrate its value chain; risks related to the timing and achievement of expected business milestones, including with respect to the construction of the 10X Facility; the availability of appropriations from the legislative branch of the federal government and the ability of the DoW to obtain funding and support for the Transactions; the determination by the legislative, judicial or executive branches of the federal government that any aspect of the Transactions was unauthorized, void or voidable; our ability to obtain additional or replacement financing, as needed; our ability to effectively assess, determine and monitor the financial, tax and accounting treatment of the Transactions, together with our and the DoW’s obligations thereunder; challenges associated with identifying alternate sales channels and customers for the highly-specialized products contemplated by the Transactions should the partnership be altered or terminated; our ability to effectively use the proceeds and utilize the other anticipated benefits of the Transactions as contemplated thereby; risks related to the Company’s long-term agreement with Apple and the Company’s ability to meet the obligations thereunder, including risks related to our ability to construct, develop and scale our facilities, technology and production; fluctuations in the pricing and volume of the magnet products to be produced under the agreement with Apple, risks related to our ability to satisfy the conditions necessary to receive the
If any of these risks materialize or the assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. The Company does not intend to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In light of these risks, uncertainties and assumptions, the forward-looking events discussed in this press release may not occur.
Use of Non-GAAP Financial Measures
This press release references certain non-GAAP financial measures, including Adjusted EBITDA, Adjusted Net Income (Loss), and Adjusted Diluted EPS, which have not been prepared in accordance with generally accepted accounting principles in
MP Materials’ management uses Adjusted EBITDA, Adjusted Net Income (Loss), and Adjusted Diluted EPS to compare MP Materials’ performance to that of prior periods for trend analyses and for budgeting and planning purposes.
Segment Information
The Company’s reportable segments, which are primarily based on the Company’s internal organizational structure and types of products, are its two operating segments—Materials and Magnetics.
The Materials segment operates the
Segment Adjusted EBITDA is management’s primary segment measure of profit or loss required by GAAP in assessing segment performance and deciding how to allocate the Company’s resources. Segment Adjusted EBITDA is calculated as segment revenues and price protection agreement income less significant segment expenses, specifically, cost of sales (excluding depreciation, depletion and amortization and stock-based compensation expense) and selling, general and administrative expenses (excluding stock-based compensation expense), as well as certain other operating expenses (referred to as “other segment items”). Significant segment expenses and other segment items also exclude certain costs that are non-recurring, non-cash or are not related to the segments’ underlying business performance.
Key Performance Indicators
NdPr Production Volume for a given period is measured in MTs, the Company’s principal unit of sale for its NdPr separated products. This measure refers to the volume of finished and packaged NdPr oxide produced at
NdPr Sales Volume for a given period is measured in MTs and on an NdPr oxide-equivalent basis (as further discussed below). NdPr Sales Volume is a key measure of our ability to convert our production of separated NdPr products into revenue. A unit, or MT, is considered sold once the Materials segment recognizes revenue on its sale, whether sold as NdPr oxide or NdPr metal, as determined in accordance with GAAP. For these NdPr metal sales, the MTs sold and included in NdPr Sales Volume are calculated based on the volume of NdPr oxide used to produce such NdPr metal. In the first quarter of 2026, to better reflect current contractual production yields, we began to utilize an assumed material conversion ratio of 1.25, such that a sale of 100 MTs of NdPr metal would be included in this KPI as 125 MTs of NdPr oxide-equivalent. Prior to this update, we utilized an assumed material conversion ratio of 1.20. The prior period amounts have not been recast. Beginning with the fourth quarter of 2025, NdPr Sales Volume for the Materials segment includes intercompany sales made to the Magnetics segment.
REO Production Volume for a given period is measured in MTs, the Company’s principal unit of sale for its concentrate product. This measure refers to the REO content contained in the rare earth concentrate we produce and includes volumes fed into downstream circuits for producing separated rare earth products, a portion of which is also included in our KPI, NdPr Production Volume. REO Production Volume is a key indicator of the mining and processing capacity and efficiency of the Company’s upstream operations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260507194592/en/
Investors:
IR@mpmaterials.com
Media:
media@mpmaterials.com
Source: